These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14529135)

  • 1. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
    Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
    J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
    Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
    J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation.
    Pedersen HD; Schütt T; Søndergaard R; Qvortrup K; Olsen LH; Kristensen AT
    J Vet Intern Med; 2003; 17(2):178-84. PubMed ID: 12683618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse.
    Olsen LH; Kristensen AT; Häggström J; Jensen AL; Klitgaard B; Hansson H; Pedersen HD
    J Vet Intern Med; 2001; 15(3):209-16. PubMed ID: 11380029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of natriuretic peptides in dogs with mitral valve disease.
    Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
    Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
    J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
    Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
    Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitral valve prolapse in 3-year-old healthy Cavalier King Charles Spaniels. An echocardiographic study.
    Pedersen HD; Kristensen BO; Lorentzen KA; Koch J; Jensen AL; Flagstad A
    Can J Vet Res; 1995 Oct; 59(4):294-8. PubMed ID: 8548691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dogs with heart diseases causing turbulent high-velocity blood flow have changes in platelet function and von Willebrand factor multimer distribution.
    Tarnow I; Kristensen AT; Olsen LH; Falk T; Haubro L; Pedersen LG; Pedersen HD
    J Vet Intern Med; 2005; 19(4):515-22. PubMed ID: 16095168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
    Beardow AW; Buchanan JW
    J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE; Singletary GE; Olsen LH; Wallace K; Häggström J; Ljungvall I; Höglund K; Reynolds CA; Pizzinat N; Oyama MA
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
    Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
    Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S; Green D; Christley R; Dukes-McEwan J
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in platelet function in Dachshunds with early stages of myxomatous mitral valve disease.
    Moesgaard SG; Sørensen TM; Sterup A; Tarnow I; Kristensen AT; Jensen AL; Olsen LH
    Res Vet Sci; 2009 Apr; 86(2):320-4. PubMed ID: 18789461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
    Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet function and activation in Cavalier King Charles Spaniels with subclinical chronic valvular heart disease.
    Tong LJ; Hosgood GL; French AT; Irwin PJ; Shiel RE
    Am J Vet Res; 2016 Aug; 77(8):860-8. PubMed ID: 27463549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Swedish breeding program for cavalier King Charles spaniels.
    Lundin T; Kvart C
    Acta Vet Scand; 2010 Sep; 52(1):54. PubMed ID: 20863375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Advia plateletcrit for assessing platelet mass in dogs, including Cavalier King Charles spaniels.
    Tvedten HW; Lilliehöök IE; Oberg J; Häggström J; Höglund K; Ljungvall I
    Vet Clin Pathol; 2012 Sep; 41(3):336-43. PubMed ID: 22954296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
    Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of platelet function in dogs with cardiac disease using the PFA-100 platelet function analyzer.
    Clancey N; Burton S; Horney B; Mackenzie A; Nicastro A; Côté E
    Vet Clin Pathol; 2009 Sep; 38(3):299-305. PubMed ID: 19392759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.